BIOPHARMX CORP Chart calendar Biopharmx Corp
e734067baf4f65531c8f8ec9671.mgd4_Vu5ob8sNNq0GLWGRv6zQD-bQdPmOm04rl_ZXEs.xXQsmynr8ecZZa77YoPpFZn7JkXuKuXUdShT3AysDyrONB_EEO35_GV9gw~4073cbb39c5110c175943058e29caed6
Upcoming events on Biopharmx Corp
No events available
Past events on Biopharmx Corp
| 30/10/2023 | Special Meeting - M&A Vote |
| 16/10/2023 | Extraordinary Shareholders Meeting - M&A Vote |
| 13/07/2023 | Society for Pediatric Dermatology Meeting |
| 02/06/2023 10:30 pm | Annual General Meeting |
| 16/05/2023 01:45 am | Q1 2023 Earnings Release |
| 01/04/2023 01:58 am | Q4 2022 Earnings Release |
| 20/12/2022 09:00 pm | Business Update Call |
| 14/11/2022 06:30 pm | Q3 2022 Earnings Release |
| 07/11/2022 11:30 pm | Extraordinary Shareholders Meeting |
| 07/09/2022 | European Academy of Dermatology and Venerology Congress - Poster Number: P1008 |
| 07/09/2022 | European Academy of Dermatology and Venerology Congress - Poster Number: P1007 |
| 07/09/2022 | European Academy of Dermatology and Venerology Congress - Poster Number: P1006 |
| 07/09/2022 | European Academy of Dermatology and Venerology Congress - Poster Number: P1005 |
| 07/09/2022 | European Academy of Dermatology and Venerology Congress - Poster Number: P1004 |
| 07/09/2022 | European Academy of Dermatology and Venerology Congress - Poster Number: P1003 |
| 07/09/2022 | European Academy of Dermatology and Venerology Congress - Poster Number: P1009 |
| 12/08/2022 02:50 am | Interim 2022 Earnings Release |
| 03/06/2022 10:30 pm | Annual General Meeting |
| 13/05/2022 01:40 am | Q1 2022 Earnings Release |
| 01/04/2022 03:14 am | FY 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,89 0,92 -3.85% | 0,08 0,08 0.22% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -10,7 -11,2 5.08% | -19,2 -20,7 7.26% |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - |
|
Net income | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - |
|
EPS | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - |
| Announcement Date | 31/03/22 | 31/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,19 0,23 -15.55% | 0,08 0,15 -44.55% | 0,00 0,15 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,20 - | 0,00 0,20 - |
|
EBIT Million USD | Released Forecast Spread | -2,80 -3,38 16.89% | -3,14 -2,65 -18.42% | -9,40 -2,85 -229.96% | -3,13 -3,90 19.82% | -3,57 -4,30 17.07% | -4,00 -3,50 -14.3% | -4,00 -3,60 -11.08% |
| Announcement Date | 31/03/22 | 12/05/22 | 11/08/22 | 14/11/22 | 31/03/23 | 15/05/23 | 21/08/23 |
More events
Past sector events for Biopharmx Corp
| 11/05/2024 01:32 am | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
| 10/05/2024 05:56 pm | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 05:30 pm | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
| 10/05/2024 04:30 pm | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 05:35 am | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
| 10/05/2024 01:45 am | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:40 am | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:39 am | XENCOR, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release |
